Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|February 8, 2020
Adipose Tumor MicroenvironmentAbbie Zewdu, Lucia Casadei, Raphael E Pollock, et al.Journal of Extracellular Vesicles|March 1, 2021
Cross-flow microfiltration for isolation, selective capture and release of liposarcoma extracellular vesiclesLucia Casadei, Adarsh Choudhury, Patricia Sarchet, et al.Plos One|July 23, 2015
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)Gonzalo Lopez, Kate Lynn J Bill, Hemant Kumar Bid, et al.Cancer|September 9, 2015
Targeting the Notch pathway: A potential therapeutic approach for desmoid tumorsHui Shang, Danielle Braggio, Ya-Jung Lee, et al.Cancer|April 14, 2019
Autophagy inhibition overcomes sorafenib resistance in S45F-mutated desmoid tumorsDanielle Braggio, David Koller, Feng Jin, et al.Plos One|November 30, 2017
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlatesGonzalo Lopez, Danielle Braggio, Abeba Zewdu, et al.Oncogene|July 12, 2020
β-catenin S45F mutation results in apoptotic resistanceDanielle Braggio, Abeba Zewdu, Priya Londhe, et al.Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.The Journal of Surgical Research|April 21, 2012
Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patientsMarcus Valadão, Danielle Braggio, Anna Flávia Santos, et al.Plos One|September 17, 2025
Blockade of interleukin-6 (IL-6) signaling in dedifferentiated liposarcoma (DDLPS) decreases mouse double minute 2 (MDM2) oncogenicity via alternative splicingAbeba Zewdu, Danielle Braggio, Gonzalo Lopez, et al.Pageof 2